SureTrader Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: nanopatent, TomP1
Search This Board:
Last Post: 6/28/2016 5:13:44 PM - Followers: 409 - Board type: Free - Posts Today: 2

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13467   * * $INO Video Chart 06-28-16 * * ClayTrader 06/28/16 05:13:44 PM
#13466   Looks bad but we know where it's going. gfunk15 06/28/16 12:56:17 PM
#13465   Interview: How This Homegrown Philly Biotech Co. Is nanopatent 06/24/16 08:20:44 PM
#13464   Fast Track designation must be requested by the nanopatent 06/22/16 06:55:46 PM
#13463   Depends how serious the spread becomes in the TomP1 06/22/16 06:15:37 PM
#13462   Factually wrong as it assumes that Sanofi was TomP1 06/22/16 06:14:39 PM
#13461   Equity analysts that regularly cover Inovio Pharmaceuticals, Inc. nanopatent 06/22/16 05:34:58 PM
#13460   Then Kim will be late as usual. kpisme 06/22/16 03:47:30 PM
#13459   Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review nanopatent 06/22/16 03:18:59 PM
#13458   Zika vaccine - Kim - "It could take nanopatent 06/22/16 03:01:19 PM
#13457   Inovio Pharmaceuticals Jumps Ahead Of Sanofi In Zika trendmkr 06/22/16 02:04:36 PM
#13456   I'm going to hold BOTH halves!! nanopatent 06/22/16 12:54:21 PM
#13455   Cramer this morning said to sell half and rustynail 06/22/16 12:51:52 PM
#13454   No idea but a short attack is likely. nanopatent 06/22/16 10:30:32 AM
#13453   Is this price drop a sell the news, DrStockonomics 06/22/16 10:28:53 AM
#13452   Wow, life is certainly not dull with INO nanopatent 06/22/16 10:25:20 AM
#13451   New seeking alpha article http://seekingalpha.com/article/3983417-inovio-gets-f Perkin78 06/22/16 10:02:01 AM
#13450   http://www.barrons.com/articles/inovio-zika-vaccine-clear-for-human-study-146652 Apenny 06/21/16 01:41:51 PM
#13449   LOCAL FIRM GETS GREEN LIGHT TO TEST ZIKA nanopatent 06/21/16 11:12:28 AM
#13448  Restored Life sucks! nanopatent 06/21/16 10:49:27 AM
#13446   What is the major scourge of mankind? nanopatent 06/21/16 10:23:26 AM
#13445   If you doubled down at $5 you would Perkin78 06/21/16 09:33:52 AM
#13444   Got in pre reverse split.. Still in red, ThatsThe1 06/20/16 09:32:49 PM
#13443   wow, congrats there! ino, gale, kerx, cldx, an harry crumb 06/20/16 09:00:38 PM
#13442   With Clay's videos, expect momentum-traders to come back TomP1 06/20/16 07:22:22 PM
#13441   I got in at a $1. nanopatent 06/20/16 07:10:41 PM
#13440   * * $INO Video Chart 06-20-16 * * ClayTrader 06/20/16 05:16:15 PM
#13439   shorts, u are so fu....! go ino, loaded harry crumb 06/20/16 04:19:46 PM
#13438   This time for what? Cancer! nanopatent 06/20/16 04:07:12 PM
#13437   Don't forget that Dr. Kim owns almost 2 quannah 06/20/16 03:15:09 PM
#13436   I like ATM financings. Just another tool Perkin78 06/20/16 03:03:20 PM
#13435   Good questions, Kim loves asking for money! This kpisme 06/20/16 01:23:35 PM
#13434   Such as? All the fancy diseases like Zika, TomP1 06/20/16 11:45:53 AM
#13433   Money will be needed for other projects in 7Bullet7 06/20/16 10:36:37 AM
#13432   Never the less new shares will be issued TomP1 06/20/16 10:32:24 AM
#13431   No dilution yet- waiting for considerable boost in 7Bullet7 06/20/16 10:15:34 AM
#13430   You forgot to mention the 50 mil dilution TomP1 06/20/16 10:00:26 AM
#13429   Phase 1 Zika trial in humans to start 7Bullet7 06/20/16 07:27:10 AM
#13428   ino is a winner harry crumb 06/07/16 09:16:43 AM
#13427   Same here! $Ino is Great! MRatt 06/06/16 10:42:40 PM
#13426   holding every single core share here, an thats harry crumb 06/02/16 10:37:09 AM
#13425   Taking Immunotherapy to the Next level nanopatent 06/01/16 12:36:35 PM
#13424   Yellow Fever nanopatent 05/26/16 11:42:05 AM
#13423   Be great when the Inovio Zika virus vaccine nanopatent 05/25/16 01:31:31 PM
#13422   ino keeps going up harry crumb 05/25/16 10:38:41 AM
#13421   New ZIKA testing method... FireFly DX makinezmoney 05/25/16 10:15:38 AM
#13420   Another pre pop this AM. nanopatent 05/24/16 08:55:07 AM
#13419   * * $INO Video Chart 05-23-16 * * ClayTrader 05/23/16 05:07:23 PM
#13418   It does help. Ino do have plenty in warrentt 05/23/16 02:55:59 PM
#13417   Strength! Nothing like it!! nanopatent 05/23/16 10:27:37 AM
PostSubject